Quasar Manufacturing Agreement to Deliver Scale & Efficiency 13/03/2019 View Appendix 4E & Preliminary Final Report 28/02/2019 View Major Brazilian Health Care Group Places Initial Pilot Order 14/02/2019 View December Quarterly Activity Report & Appendix 4C 31/01/2019 View Australian Distribution Agreement for 9000 HeraBEAT Units 14/01/2019 View December Investor Presentation 19/12/2018 View Becoming a substantial holder – Holley Pharmaceutical Group 19/12/2018 View HeraMED Completes Over-Subscribed $6 Million IPO 12/12/2018 View Becoming a substantial holder – Tal Slonim 11/12/2018 View Becoming a substantial holder – David Groberman 11/12/2018 View Initial Director’s Interest Notice – Tal Slonim 11/12/2018 View Initial Director’s Interest Notice – Ronald Weinberger 11/12/2018 View Initial Director’s Interest Notice – Doron Birger 11/12/2018 View Initial Director’s Interest Notice – David Hinton 11/12/2018 View Initial Director’s Interest Notice – David Groberman 11/12/2018 View Statement of Confirmations 10/12/2018 View Updated Statement of Commitments 10/12/2018 View Voluntary Escrow 10/12/2018 View Restricted Securities 10/12/2018 View Updated Pro Forma Statement of Financial Position 10/12/2018 View Capital Structure 10/12/2018 View Securities Trading Policy 10/12/2018 View Hera Med Ltd. Half Yearly Accounts to 30 June 2018 10/12/2018 View Hera Med Ltd. 2016 and 2017 Full Year Accounts 10/12/2018 View Supplementary Prospectus 10/12/2018 View Prospectus 10/12/2018 View Constitution 10/12/2018 View Appendix 1A and Information Form and Checklist 10/12/2018 View Top 20 Holders 10/12/2018 View Distribution Schedule 10/12/2018 View ASX Notice – Admission to Official List 10/12/2018 View
Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok Terms of Use